Navigation Links
New Medicare Equipment Bidding Program for Riverside, California Area is Rife with Errors, Says the American Association for Homecare
Date:4/7/2008

care and reimbursement rates for oxygen have already been cut by nearly 50 percent over the past 10 years. The DME industry has long argued that this new program will needlessly punish established, high-quality providers, reduce the DME industry's focus on service, and harm patient access to care.

The DME industry consists primarily of small to medium-sized businesses serving relatively small service areas. The average DME company receives about 50 percent of its business from Medicare patients. Loss of this business will result in layoffs and business failure for many DMEs.

"The Secretary of Health and Human Services has called home-based healthcare 'radically' more efficient than institutional care, yet the federal government is determined to aggressively dismantle the nation's homecare infrastructure at a time when our healthcare system needs it the most," said Tyler J. Wilson, president of the American Association for Homecare. "DME spending is the smallest sliver of Medicare, less than two percent of spending, and is the slowest-growing segment. Taxpayers may ultimately face higher costs as hospital stays lengthen due to more complicated hospital discharge logistics, more emergency room visits, and cost-shifting from Medicare Part B to Part A services."

The American Association for Homecare is pursuing regulatory, legislative, and legal remedies to allow for review of the cases of those DME providers that have been disqualified and is calling for the suspension of the first round of the bidding program until questions about patient access and harm to DME providers can be fully assessed.

The American Association for Homecare (AAHomecare) represents providers of durable medical equipment and related services and supplies as well as equipment manufacturers. AAHomecare members serve the medical needs of millions of Americans who require home oxygen equipment, wheelchairs and other mobility products, hospital beds, medical supplie
'/>"/>

SOURCE American Association for Homecare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
2. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
3. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
4. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
5. AHCA: Rescinding $2.7 Billion Medicare Cuts Top Issue for Fall Legislative Agenda
6. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
7. Medicare Spending Caps Cause Seniors to Stop Meds
8. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
9. Medicare Every Diabetic Counts Project Gears Up for Kick-Off
10. Medicare Cuts to Physicians Will Harm Washington Seniors
11. More than 10,000 Medicare Patients in Montana Could Be Hit by Proposed Cuts to Home Oxygen Therapy; Access to Power Wheelchairs Would Also Decrease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...ntion Research Center will bring tailored programs...e abuse . The outcome is based on decades of resea...ther high-risk behaviors of teenagers and adults. ...ion, 5-year grant from the National Institute of D...
...y soon impact the quality of patient care for asth...port. Without intervention, the number of allergy... 7 percent while demand will increase by 35 percen...ears, said ACAAI President Daniel Ein, M.D. The d...
...y warned consumers could be seriously misled by pr...mission to Food Standards Australia and New Zealan... manufacturers are likely to confuse consumers and... unhealthy diets. The food industry wants to put...
...ensitive caption for the picture of an abandoned b... a pre-schooler was found left in a cardboard box... The drop-off was opened by the Catholic-run Jikei...oto to discourage abortions and the abandonment of...
Other Medicine News:Health News:New Substance Use Prevention Program Being Developed 2Health News:New Substance Use Prevention Program Being Developed 3Health News:New Substance Use Prevention Program Being Developed 4Health News:America on Brink of Allergy Crisis 2Health News:Three-year-old Abandoned in Box Meant for Unwanted Babies in Japan 2
(Date:7/22/2008)...is Technology in the European ...wswire-FirstCall/ -- Cynosure, Inc.,(Nasdaq: CYNO...d array of,light-based aesthetic treatment systems...MPX(TM), the company,s high-powered, dual-waveleng...n skin through collagen,remodeling. The CE Mark ce...
(Date:7/21/2008)... as consolidation therapy after remission inducti...r lymphoma, SEATTL...tics, Inc.,(CTI) (Nasdaq and MTA: CTIC) announced ...h the U.S. Food and Drug Administration (FDA) in S...pplemental Biologics License,Application (sBLA) fo...
(Date:7/21/2008)...008 conferences, GAITHERSBURG, Md., July 21 /PRNe...ompany developing gene therapies for HIV and genet...Phase I and Phase II,clinical trials for the media...an investigational gene therapy for the treatment ...day, July 24, 2008 at 11 a.m. EDT. The,presentatio...
(Date:7/21/2008)...h in Italy continue, FRANKLIN, Mass., July 21 /PR...C ) announced today that it will defer the commenc...TM) System in the prevention of,Contrast-Induced N... the,investigator-sponsored clinical trial now ong... launch of RenalGuard in Europe, which began in th...
Breaking Medicine Technology:Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 3PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 4PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 5Statehouse Atrium to be Site for Childrens Dental Access Event Ohio Legislators to Mingle With Children and Dentists for This Free Care Event 21 9781 1Statehouse Atrium to be Site for Childrens Dental Access Event Ohio Legislators to Mingle With Children and Dentists for This Free Care Event 21 9781 2Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28 2008 2664 1Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28 2008 2664 2Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28 2008 2664 3Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV I HTLV II 2662 1Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV I HTLV II 2662 2Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV I HTLV II 2662 3Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 2660 1Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 2660 2Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 2660 3
... Rexahn,Pharmaceuticals, Inc. (OTC BB:RXHN), a bio... development, and commercialization of,innovative ...rders,sexual dysfunction and other unmet medical ...ncipal Investigator of Phase I clinical,trial of t...n),will present results of the clinical study at ...
...n Transplantation, HORSHOLM, Denmark, May 31, 2007...ces positive Phase I clinical results for,its tran...nto US,Phase II clinical trials for organ transpla...nounces positive results,from its Phase I clinical...aily tacrolimus tablet. , A series of Phase I tria...
Other Medicine Technology:LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3
GENTAMICIN SULFATE, 1000X
Gentamicin is a selection antibiotic used for selection of a Bac-to-Bac recombinant expression bacmid following transposition. Gentamicin is provided as a solution at a concentration of 50 mg/ml.
1.0% Tryptone, 0.5% yeast extract, 0.5% Sodium Chloride, 1.5% agarose.
1% tryptone, 0.5% yeast extract, 1.0% Sodium Chloride, 1.5% agar.
Medicine Products: